The office gives technical assistance and links firms to the agency
What the document says“provide technical assistance to regulatory partners in Abraham Accords countries on strengthening regulatory oversight and converging regulatory requirements for the oversight of regulated products, including good manufacturing practices”
Once established, the office must provide technical assistance to regulatory partners in those countries on strengthening oversight and bringing requirements closer together, including good manufacturing practices and other issues relevant to making medical products. It must also make it easier for interested parties there to deal with the agency, including by sharing information on United States regulatory pathways and gathering feedback on research, development and manufacturing. It carries out other functions the Secretary finds necessary.
What the document actually says“provide technical assistance to regulatory partners in Abraham Accords countries on strengthening regulatory oversight and converging regulatory requirements for the oversight of regulated products, including good manufacturing practices”
The office helps the drug watchdogs in those countries. It works on stronger oversight and on rules that line up with each other.
Good manufacturing practice is the way medicine must be made. Rules that match make trade and checks easier for both sides.
No action is recorded against this proposal. That is not evidence that none has been taken, and nobody has yet read it against the record. See what the tracker does not yet cover.